The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...

The UniverXome subsidiary was established prior to Serina’s reverse merger with AgeX Therapeutics in March 2024 to own the legacy assets of the predecessor company.

The U.S. Department of Defense has awarded up to $11.9 million to Oregon State University to invent new drug delivery ...

We won’t tolerate public officials breaching the public’s trust to help criminals, whether they are family or not.” ...

As deadly fires continue to rage in Los Angeles, healthcare companies far and wide are stepping up to serve those affected.

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Mushroom coffee is trending again. We dive into the cost, taste and potential health benefits of ditching your normal cup of ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, INS1201.

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI, about ...

NEW YORK, NY / ACCESSWIRE / / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the successful results of ...